avapro and cyclin d1
avapro has been researched along with cyclin d1 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Du, N; Feng, J; Hu, LJ; Ren, H; Sun, HB; Sun, X; Yang, YP; Zhao, Y | 1 |
Other Studies
1 other study(ies) available for avapro and cyclin d1
| Article | Year |
|---|---|
Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Apoptosis; Biphenyl Compounds; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; CREB-Binding Protein; Cyclin D1; Female; Humans; Irbesartan; Mitogen-Activated Protein Kinases; NF-kappa B; Proliferating Cell Nuclear Antigen; raf Kinases; ras Proteins; Receptor, Angiotensin, Type 1; RNA Interference; RNA, Small Interfering; Signal Transduction; Tetrazoles; Tumor Suppressor Protein p53 | 2012 |